Inmune Bio Inc. (INMB)
Sector: | Health Care |
Super Investor Stats: | |
Ownership count: | 0 |
Ownership rank: | -- |
% of all portfolios: | 0% |
| |
Total insider Buys/Sells last 6 months: |
| Transactions | Total |
Buys |
0 |
$0 |
Sells |
0 |
$0 |
|
Portfolio Manager |
% of portfolio |
Recent activity |
Shares |
Value |
Open Market Insider Buys
Date Filed |
Reporting Name |
Relationship |
Trans. Date |
Shares |
Price $ |
Total Value $ |
13 Nov 2023 |
JUDA SCOTT |
Director |
10 Nov 2023 |
7,000 |
6.95 |
48,650 |
20 Mar 2023 |
MOSS DAVID J |
CFO, Treasurer & Secretary, 10% |
17 Mar 2023 |
2,500 |
6.42 |
16,062 |
31 May 2022 |
TESI RAYMOND JOSEPH |
President and CEO, 10% |
26 May 2022 |
6,300 |
6.41 |
40,383 |
31 May 2022 |
MOSS DAVID J |
CFO, Treasurer & Secretary, 10% |
27 May 2022 |
3,000 |
6.79 |
20,370 |
31 May 2022 |
MOSS DAVID J |
CFO, Treasurer & Secretary, 10% |
26 May 2022 |
7,700 |
6.27 |
48,279 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock